This one sort of piggybacks on your comments on food, but it also diverges a little. So I'll go two parts. So can you give me your current thoughts on expanding into new or adjacent markets, such as QSRs, so that'd be food related, and then healthcare, not food related, but compliance related?
Randy Fields: I think the first thing to realize is that when we thought about Rule 204, and this was an error we made in looking into the future, Rule 204 for from the FDA covers, call it, 5% to 7% of the food products that go through a supermarket. Keep that number in mind, 5% to 7%. What just happened is, the industry said, we're going to go from 5% to 7% to 100%. So you can work the numbers out, it's between a 15 and 20 time expansion of the size of the opportunity. And frankly, a more difficult part of the opportunity, because most of the participants that are going to have to do traceability had never thought of it, hadn't considered it because they were exempt from the rule, but they were part of it. And now they're part of the competitive aspect of doing traceability. So just in the grocery space, the opportunity is more than one order of magnitude larger than we guessed. That means that our appetite for other vertical markets is shrinking. On the other hand, most of the suppliers that we work with in retail food, if you will, in the grocery space, also do work in each of those other vertical markets. So we may not be end to end in the QSR and other spaces, we will be end to end in grocery, but we may be from end to middle in terms of the other segments of places where food is consumed. So it's not a missed opportunity. It's the one that we're in just grew by 10 times, maybe more. In fact, it's certainly more than 10 times.